BioWorld

Jan. 22, 2002

House Committee Investigating ImClone’s Handling Of Erbitux

WASHINGTON A House committee on Friday said it will investigate New York-based ImClone Systems Inc.’s conduct in the development of its well-publicized drug for colorectal cancer. Read More

Pharmacopeia, Eos Scrap Merger Following Shareholder Opposition

Harvard Immunologist, California Firm Join In Hunt For Drugs To Check Human Asthma Onslaught

BIO’s Agenda Includes Quick Appointment Of FDA Leader

Holiday Notice

Other News To Note

Triangle Plans NDA For One Drug, Discontinues Another

Today's news in brief

BioWorld

BioWorld briefs for June 24, 2026.

Have brain-computer interfaces finally arrived?

BioWorld

More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 23, 2026

2026 marks critical turning point for BCI technology

BioWorld

Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...

Brain-computer interfaces are here but long road ahead

BioWorld

The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...